Topoisomerase I deregulation in laryngeal squamous cell carcinomas based on tissue microarray analysis.
CONCLUSIONS: Topo I overexpression is observed in a significant subset of LSCCs affecting the level of differentiation in them. Additional molecular studies focused on the mechanism of Topo I gene/protein deregulation (i.e. amplification, abnormal epigenetic promoter methylation, mRNA aberrant expression) are necessary discriminating the eligible patients for applying specific chemotherapeutic strategies based on anti-Topo I agents.
PMID: 28730788 [PubMed - in process]
Source: Journal of B.U.ON. - Category: Cancer & Oncology Tags: J BUON Source Type: research
More News: Cancer & Oncology | Carcinoma | Chemotherapy | Genetics | Laryngeal Cancer | Squamous Cell Carcinoma | Statistics | Study